Showing 201-210 of 8690 results for "".
Neuromodulators in Medical Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/neuromodulators-in-medical-dermatology/18520/Physicians are exploring the effects of botulinum toxins on several medical dermatology conditions. Erin Gilbert, MD talks to Joel Cohen, MD about her experience treating rosacea, and discusses the need for better randomized trials to explore treatment options.On the Leading Edge, Not the Bleeding Edge: Joe Niamtu, DMD
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/on-the-leading-edge-not-the-bleeding-edge-joe-niamtu-dmd/18606/Innovator, influencer, and podium perennial Joe Niatmu, III, DMD has built a successful surgical aesthetic practice by focusing on the basics, concentrating on his strengths, and avoiding passing fads. How does he stay passionate, spot the best new developments, and build a fulfilling practice? In tThe Benjamin Button Effect: Noninvasive Rejuvenation
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-benjamin-button-effect-noninvasive-rejuvenation/18813/Heidi Waldorf, MD explains her approach to helping patients achieve the best, most natural results from noninvasive rejuvenation. She says her patients want to look like themselves after aesthetic treatment—but a healthier, more youthful version of themselves. Dr. Waldorf shares tips for interactingValeant Acquires Salix; Actavis Changing Name
https://practicaldermatology.com/series/dermwire-tv/valeant-acquires-salix-actavis-changing-name/18963/Valeant expands its portfolio with the acquisition of GI market leader Salix. Actavis divests Doryx and considers a name change to Allergan. Kythera acquires rights for investigational hair therapies. And Cynosure's 532nm laser delivery system is FDA cleared for PicoSure.NPS and Your Practice
https://practicaldermatology.com/topics/practice-management/nps-and-your-practice/19226/Ekwa Marketing explains NPS (net promoter survey) to doctors, dentists and other medical professionals.Part 6, 1726 nm lasers: Growing the market for the 1726 nm wavelength lasers
https://practicaldermatology.com/series/scientifically-speaking/1726-nm-lasers-five-dermatologists-discuss-the-lasers-benefits-and-drawbacks-for-treating-acne-and-other-skin-conditions/24344/Chapter 6 of 7: David Goldberg, MD, from New York, Emil Tanghetti, MD, from Sacramento, Jordan Wang, MD, from Philadelphia and New York and Naz Saedi, MD, from Philadelphia talk about the growing the market for the 1726 nm wavelength lasers.New Hope for Patients with Onychomycosis
https://practicaldermatology.com/issues/practicaldermatology-com-march-2025/new-hope-for-patients-with-onychomycosis/33161/Onychomycosis, a non-self-healing fungal infection of the toenails or fingernails, is a common infection accounting for 20% of all nail diseases in adults, affecting 5% of the worldwide population.FDA Approves New AD Treatment; Study Examines Omega-3 Fatty Acids in Managing Acne
https://practicaldermatology.com/series/dermwire-tv/fda-approves-new-ad-treatment-study-examines-omega-3-fatty-acids-managing-acne/26664/In this week’s DermwireTV, a new steroid-free treatment option for children and adults living with AD is approved by the FDA; research examines the potential benefits of omega-3 fatty acids in managing acne severity; Modern Aesthetics announces plans to relaunch its news broadcast; and Andrew MastroDermWireTV Extra: Lubriderm Launches Skin Scholarship with the NHHF
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-extra-lubriderm-launches-skin-scholarship-with-the-nhhf/20060/Suzanne Goldstein, Senior Director of Marketing for Lubriderm, explains the Skin Scholarship sponsored by Lubriderm and created in partnership with the National Hispanic Health Foundation (NHHF). This scholarship program aims to increase representation and accessibility within the field.Exploring High-Dose Neurotoxin Injections
https://practicaldermatology.com/conferences/maui-derm-2022/exploring-high-dose-neurotoxin-injections/20055/Michael H. Gold, MD shares his thoughts on the potential benefits of high-dose neurotoxin injections for some patients. He discusses his experience and the kind of results he's been able to achieve.